About
About Bioventix PLC
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Visit company website
5 years, 5 months ago
Bioventix PLC is currently in a long term downtrend where the price is trading 5.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.7.
Finally, its free cash flow fell by 20.9% to $2M since the same quarter in the previous year.
Based on the above factors, Bioventix PLC gets an overall score of 1/5.